Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Operating Expenses (2020 - 2022)

Sonoma Pharmaceuticals (SNOA) has 3 years of Operating Expenses data on record, last reported at $3.2 million in Q4 2012.

  • For Q4 2012, Operating Expenses fell 25.08% year-over-year to $3.2 million; the TTM value through Mar 2013 reached $10.5 million, down 30.52%, while the annual FY2012 figure was $15.2 million, 11.25% up from the prior year.
  • Operating Expenses reached $3.2 million in Q4 2012 per SNOA's latest filing, down from $4.0 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $4.2 million in Q4 2011 and bottomed at $3.2 million in Q4 2012.
  • Average Operating Expenses over 3 years is $3.6 million, with a median of $3.4 million recorded in 2011.
  • Peak YoY movement for Operating Expenses: surged 30.34% in 2011, then fell 25.08% in 2012.
  • A 3-year view of Operating Expenses shows it stood at $3.2 million in 2010, then soared by 30.34% to $4.2 million in 2011, then dropped by 25.08% to $3.2 million in 2012.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $3.2 million in Q4 2012, $4.0 million in Q3 2012, and $3.4 million in Q2 2012.